ProCE Banner Activity

Changing How We Treat Relapsed/Refractory Hairy Cell Leukemia

Slideset Download
Farhad Ravandi, MD, examines evolving new approaches to hairy cell leukemia, including the antibody-drug conjugate moxetumomab pasudotox, BRAF inhibitors, and combination regimens.

Released: April 24, 2019

Expiration: April 22, 2020

No longer available for credit.

Share

Faculty

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas